echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Chain pharmacy giants accelerate the deployment of "dual channels", what should small and medium-sized chains do?

    Chain pharmacy giants accelerate the deployment of "dual channels", what should small and medium-sized chains do?

    • Last Update: 2022-05-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    "Dual-channel" means that when the hospital cannot guarantee the medication of the inpatients in time, the doctor can prescribe the drug through the "dual-channel" system of the national medical insurance negotiation drug
    .
    After being reviewed by the hospital, the prescription will be randomly transferred to the pharmacy that has the medicines in stock.
    After the pharmacy reviews and confirms the order, it will be delivered to the corresponding hospital free of charge
    .
    Since 2019, an increasing number of provinces and prefectures have introduced a "dual-channel" model, leveraging the flexibility of retail pharmacies to expedite the delivery of high-priced medicines covered by medical insurance outside the hospital
    .
    Especially in May 2021, the National Medical Insurance Administration and the National Health and Health Commission jointly issued the "Guiding Opinions on Establishing and Improving the "Dual Channel" Management Mechanism for National Medical Insurance Negotiation Drugs", which was the first time to include designated retail pharmacies in the supply of medical insurance drugs at the national level.
    The scope of protection meets the reasonable needs of negotiated drug supply guarantee, clinical use, etc.
    , and has been simultaneously included in medical insurance payment.
    The development process of "dual-channel" in various regions has begun to accelerate.
    Currently, Guangdong, Hunan, Jiangsu, Zhejiang, Anhui, Henan, Hebei , Fujian and other provinces have released the list of "dual-channel" management drugs
    .
    It is worth noting that with the continuous influence of the "dual-channel" policy, many pharmacies are gaining more and more new opportunities, and at the same time, they are also further increasing their retail market share
    .
    Take Dashenlin as an example.
    At the end of last month, Dashenlin announced that the company will add 115 new stores in 2021 to obtain dual-channel overall planning qualifications, covering 7 provinces and 31 prefecture-level cities
    .
    At present, there are more than 900 hospital-side pharmacies in Dashenlin, of which 504 pharmacies are qualified for dual-channel medical insurance financing for various diseases (covering serious diseases, special diseases, and chronic diseases), and there are 120 DTP specialty pharmacies
    .
    In addition, the People's Pharmacy also announced last month that as of January 21, 2022, a total of 119 stores of the People's Pharmacy nationwide have obtained the qualification for dual-channel overall planning, covering a total of 11 provinces including Hunan, Guangxi, Zhejiang, Henan, Shandong, etc.
    1 There are 47 municipalities directly under the Central Government and 47 prefecture-level cities
    .
    It is reported that at the beginning of 2016, the People's Pharmacy established the "New Special Drug Division", and now there are nearly 1,000 hospital side stores and 145 DTP professional pharmacies..
    It is worth mentioning that, on this basis, the People's Pharmacy also said that this year, it will continue to increase the access to dual-channel medical insurance qualifications with its own network and layout advantages
    .
    At present, from an overall point of view, it should be noted that due to the relatively high application requirements for "dual-channel" pharmacies and higher requirements for practicing physicians, large chains have more advantages in the "dual-channel" market However, there are certain challenges for small and medium-sized chains to share the "dual-channel" cake.
    Under this background, how should small and medium-sized chain drugstores operate and strive for more development opportunities? The analysis believes that relevant enterprises can firstly use the Internet to vigorously develop online marketing
    .
    Under the new situation, more and more enterprises have begun to actively embrace the Internet and use the Internet to open the door for enterprise development
    .
    Of course, in addition to this, you can also carry out diversified operations and multi-faceted trading of big health products
    .
    But in general, no matter what kind of business model small and medium-sized chain pharmacies adopt, survival is the first factor, and development is the last word.
    Only by staying close to the market, facing the needs of the public, adapting to the current medical situation, and constantly innovating its own operation model, can we Have long-term competitiveness
    .
    Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
    .
     
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.